CanSino Biologics Announces Board Changes

CanSino Biologics, Inc. Class H (HK:6185) has released an update.

CanSino Biologics Inc. has announced the resignation of Ms. Nisa Bernice Wing-Yu LEUNG as a non-executive Director and a member of the Nomination Committee, effective May 30, 2024, due to her personal work arrangements. In her stead, Mr. Chi Shing LI, with a substantial background in healthcare management and venture capital, has been nominated for these positions, pending approval at the annual general meeting. The company expressed gratitude to Ms. Leung for her contributions and confirmed that Mr. Li’s appointment carries no undisclosed concerns.

For further insights into HK:6185 stock, check out TipRanks’ Stock Analysis page.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.